SynthesisTrials2022

Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.

Olalekan Lee Aiyegbusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.